ATE547111T1 - Methode zur herstellung eines transfer faktor medikaments - Google Patents

Methode zur herstellung eines transfer faktor medikaments

Info

Publication number
ATE547111T1
ATE547111T1 AT07721839T AT07721839T ATE547111T1 AT E547111 T1 ATE547111 T1 AT E547111T1 AT 07721839 T AT07721839 T AT 07721839T AT 07721839 T AT07721839 T AT 07721839T AT E547111 T1 ATE547111 T1 AT E547111T1
Authority
AT
Austria
Prior art keywords
medicament
transfer factor
manufacturing
lyophylisation
normalisation
Prior art date
Application number
AT07721839T
Other languages
English (en)
Inventor
Jan Pekarek
Original Assignee
Sevapharma A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sevapharma A S filed Critical Sevapharma A S
Application granted granted Critical
Publication of ATE547111T1 publication Critical patent/ATE547111T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/17Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
AT07721839T 2006-06-13 2007-06-12 Methode zur herstellung eines transfer faktor medikaments ATE547111T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20060377A CZ299296B6 (cs) 2006-06-13 2006-06-13 Lécivo transfer faktor - zpusob výroby a použití
PCT/CZ2007/000050 WO2007143957A2 (en) 2006-06-13 2007-06-12 'transfer factor' medicament - ways of manufacturing and use

Publications (1)

Publication Number Publication Date
ATE547111T1 true ATE547111T1 (de) 2012-03-15

Family

ID=38220655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07721839T ATE547111T1 (de) 2006-06-13 2007-06-12 Methode zur herstellung eines transfer faktor medikaments

Country Status (9)

Country Link
EP (1) EP2037949B1 (de)
AT (1) ATE547111T1 (de)
CY (1) CY1113372T1 (de)
CZ (1) CZ299296B6 (de)
DK (1) DK2037949T3 (de)
ES (1) ES2383351T3 (de)
PL (1) PL2037949T3 (de)
SI (1) SI2037949T1 (de)
WO (1) WO2007143957A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX338863B (es) 2011-12-16 2016-05-01 Inst Politecnico Nacional Metodo de obtencion de extracto dializable de leucocitos.
CZ2020342A3 (cs) * 2020-06-12 2021-12-22 AUMED, a.s. Způsob přípravy léčiva transfer faktor, léčivo transfer faktor, metodika testování biologické účinnosti, léková forma a její použití
CN113304172A (zh) * 2021-06-10 2021-08-27 哈尔滨圣泰生物制药有限公司 一种转移因子口服溶液的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
NO793412L (no) * 1978-10-25 1980-05-06 Benzon As Alfred Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
ZA835244B (en) * 1982-07-20 1985-02-27 Bio Com Inc Transfer factor for use in treating viral infections
DE3244607A1 (de) * 1982-12-02 1984-06-07 Bezirksblutspendezentrale Plauen, DDR 9900 Plauen Verfahren zur herstellung von humanen transfer-faktor-praeparaten
ATE158184T1 (de) * 1990-07-02 1997-10-15 Nat Jewish Ct Immun & Respirat Herstellung und verwendung von transfer-faktor
CN1093907A (zh) * 1993-12-19 1994-10-26 陕西省生物制品研究所 口服转移因子
MXPA02002171A (es) * 2002-02-28 2002-12-09 Antonio Calzada Nova Luis Extracto de leucocitos dializado en la elaboracion de un farmaco para el tratamiento de enfermedades infecciosas en animales.
CN100413534C (zh) 2003-11-03 2008-08-27 西北农林科技大学 一种治疗奶牛临床乳房炎的生物性免疫制剂及其制作方法
CN1654477A (zh) 2004-02-13 2005-08-17 北京世纪昭宝转移因子研究中心 制备转移因子工艺方法-加热法

Also Published As

Publication number Publication date
CY1113372T1 (el) 2016-06-22
ES2383351T3 (es) 2012-06-20
DK2037949T3 (da) 2012-06-18
EP2037949A2 (de) 2009-03-25
EP2037949B1 (de) 2012-02-29
SI2037949T1 (sl) 2012-07-31
WO2007143957B1 (en) 2008-06-26
CZ2006377A3 (cs) 2007-07-04
CZ299296B6 (cs) 2008-06-11
WO2007143957A3 (en) 2008-05-08
WO2007143957A2 (en) 2007-12-21
PL2037949T3 (pl) 2012-10-31

Similar Documents

Publication Publication Date Title
WO2007118235A3 (en) Filtration system for preparation of fluids for medical applications.
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
BRPI0821027B8 (pt) 4-(4-ciano-2-tioaril)di-hidropirimidinonas para tratamento e/ou prevenção de lesões do pulmão e do sistema cardiovascular, seu processo de preparação e seu uso, e medicamento
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
MY159377A (en) Aqueous suspensions of ciclesonide for nebulisation
MX352281B (es) Dihidroxi-clorinas glico-sustituidas y clorinas beta-funcionalizadas para terapia fotodinamica anti-microbiana.
BR112021019663A2 (pt) Método para produzir microvesículas terapêuticas, composição probiótica, microvesículas terapêuticas, e, cepa bacteriana
ATE547111T1 (de) Methode zur herstellung eines transfer faktor medikaments
Twardowski et al. Peritoneal dialysis access and exit-site care including surgical aspects
ZA200908583B (en) Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation
SE0301577L (sv) Lösning med låg natriumhalt
CN101612199A (zh) 治疗眼睛红肿和遇风流泪的冲洗液
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
CN202459574U (zh) 一种输液装置
BR112014005221A2 (pt) uso de materiais de fibra oca modificada para a remoção de exotoxinas produzidas por escherichia coli a partir de liquidos, de preferência a partir de sangue e de plasma, bem como seu uso para o tratamento de doenças concomitantes
CN106234440A (zh) 一种高效消毒液
CN201692228U (zh) 一种护士用臂套
ATE506946T1 (de) Verbindung zur prävention und behandlung von linksventrikulärer hypertrophie bei dialyse- patienten
Macy Did Nikola Tesla Discover a Treatment for COVID-19 Over a Hundred Years Ago?
CN206304151U (zh) 专人专用体温表消毒盒
Correll et al. Selective Effect s of Individual Antipsychotic Cotreatments on Cardiometabolic and Hormonal Risk Status: Results from a Systematic Review and Meta-analysis
Supajatura et al. Mangosteen spray for efficacious treatment of streptococcal pharyngitis
Kamil et al. THE IMPLEMENTATION OF PATIENT SAFETY BY NURSES IN INPATIENT ROOMS OF PUSKESMAS PIDIE AND PUSKESMAS PIDIE JAYA
Manjunath et al. Outbreak of Burkholderia cepacia bacteraemia in a haemodialysis unit.